Literature DB >> 9222743

Hepatocellular carcinoma in a non-cirrhotic coal miner with secondary haemochromatosis.

J De Tomás1, A Louredo, F Turégano, A Alonso, M R Martín-Merino.   

Abstract

We report a case of hepatocarcinoma in a non-cirrhotic patient with secondary haemochromatosis. A 61-year-old man, who had been a coal miner for 36 years, presented with a well differentiated hepatocarcinoma without cirrhosis. The patient had a haemochromatosis with no family history of liver disease and a normal genetic study. Right hepatectomy was performed and 15 months later there has been no recurrence. This case confirms the possibility of hepatocarcinoma occurring in haemochromatosis patients without cirrhosis. The recognition of populations at risk of haemochromatosis is a necessity, and this should include coal miners.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222743     DOI: 10.1097/00042737-199706000-00020

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  A Case Report of Hepatocellular Carcinoma in a Non-cirrhotic Patient With Liver Iron Overload Associated With Myelodysplastic Syndrome.

Authors:  Naruhiko Ikoma; Hiroharu Shinozaki; Akihito Kozuki; Sho Ibuki; Kokichi Sugano; Makio Mukai; Yoshihiro Masuda; Kenji Kobayashi; Yoshiro Ogata
Journal:  World J Oncol       Date:  2014-01-16

Review 2.  MRI Appearance of Focal Lesions in Liver Iron Overload.

Authors:  Anna Pecorelli; Paola Franceschi; Lorenzo Braccischi; Federica Izzo; Matteo Renzulli; Rita Golfieri
Journal:  Diagnostics (Basel)       Date:  2022-04-02

3.  Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.

Authors:  Ryo Yamauchi; Kazuhide Takata; Yoshinobu Shinagawa; Takashi Tanaka; Hiromi Fukuda; Sho Fukuda; Hideo Kunimoto; Kaoru Umeda; Daisuke Morihara; Keiji Yokoyama; Yasuaki Takeyama; Makoto Irie; Satoshi Shakado; Mikirou Mizoguchi; Satoshi Hisano; Kengo Yoshimitsu; Shotaro Sakisaka
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.